Business Standard
Ø No free ride for quasi equity in Mauritius pact
Ø ndia seeks to pay $6.5B to Iran for oil imports
Ø Have enough minefields already, don't want any more: Rajan
Ø P-Notes: Foreign investors fine with key Sebi proposals
Ø India third in attractiveness index of renewable energy: Report
Ø Those making money in India must pay taxes: Jaitley
Ø April this year was hottest on record, finds NASA
Ø We need healthier PSU banks; wait for a few days: Arun Jaitley
Ø Precision tool to get speed on e-commerce profit road
Ø Sebi readies dividend distribution policy for top 500 firms
Ø 'Brexit' can open up opportunities for India: Report
Ø EPFO may invest over Rs 6,000 cr in equity market in 2016-17
Ø Stock market turnover slides 43% in Jan-April this year
Ø Coal India to offer 79 million tonnes coal for e-auction
Business Line
Ø Jaitley: Mauritius tax treaty revision not to hit FDI
Ø Global investors return to gold ETFs
Ø Govt to reward departments for going paperless
Ø Norms for road projects will be diluted: Nitin Gadkari
Ø ‘New products will drive growth at Dr Reddy’s’
Ø India using buying power to beat down crude oil prices
Mint
Ø Sebi planning to tighten listing norms
Ø GE Power India to grow 50% in 2016: Steve Bolze
Ø G7 to take steps on global steel glut-draft
Ø Amazon reveals it owns indirect minority stake in India third-party seller
Ø SAIL lines up Rs6,000 crore capital expenditure for FY17
Financial Express
Ø Overseas investors sell Rs 178 crore worth shares in 2 weeks
Ø Centre sets into motion second phase of PMUY
Ø Google faces record 3 bln euro EU antitrust fine: Telegraph
Ø Hero Cycles files lawsuit against Avon on IPR 'violation'
Ø 12 per cent of India's land mass vulnerable to landslide: GSI
Ø Mother Dairy eyes Rs 10k-cr turnover in 3 years
Financial Chronicle
Ø Retail sector to grow from $600b to $1 trillion by 2020
Ø Sarovar Hotels gets all set for African foray
Ø New tea e-auction platform set to ease pan-India trading
Ø Mutual funds folio count rises 4 lakh to 4.8 crore
Ø Piramal to acquire 4 brands of Pfizer
No comments:
Post a Comment